{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T23:58:58Z","timestamp":1770508738330,"version":"3.49.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2009,12,5]],"date-time":"2009-12-05T00:00:00Z","timestamp":1259971200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1007\/s10689-009-9311-3","type":"journal-article","created":{"date-parts":[[2009,12,4]],"date-time":"2009-12-04T12:59:00Z","timestamp":1259931540000},"page":"213-220","source":"Crossref","is-referenced-by-count":19,"title":["Female BRCA mutation carriers with a preference for prophylactic mastectomy are more likely to participate an educational-support group and to proceed with the preferred intervention within 2\u00a0years"],"prefix":"10.1007","volume":"9","author":[{"given":"Karin M.","family":"Landsbergen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith B.","family":"Prins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvonne J. L.","family":"Kamm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han G.","family":"Brunner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicoline","family":"Hoogerbrugge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,12,5]]},"reference":[{"key":"9311_CR1","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","volume":"72","author":"A Antoniou","year":"2003","unstructured":"Antoniou A, Pharoah PD, Narod S et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72:1117\u20131130","journal-title":"Am J Hum Genet"},{"key":"9311_CR2","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1093\/jnci\/94.18.1365","volume":"94","author":"MS Brose","year":"2002","unstructured":"Brose MS, Rebbeck TR, Calzone KA et al (2002) Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program. J Natl Cancer Inst 94:1365\u20131372","journal-title":"J Natl Cancer Inst"},{"key":"9311_CR3","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1200\/JCO.2006.09.1066","volume":"25","author":"S Chen","year":"2007","unstructured":"Chen S, Parmigiani G (2007) Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol 25:1329\u20131333","journal-title":"J Clin Oncol"},{"key":"9311_CR4","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1086\/301749","volume":"62","author":"D Ford","year":"1998","unstructured":"Ford D, Easton DF, Stratton M et al (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The breast cancer linkage consortium. Am J Hum Genet 62:676\u2013689","journal-title":"Am J Hum Genet"},{"key":"9311_CR5","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1056\/NEJM199705153362001","volume":"336","author":"JP Struewing","year":"1997","unstructured":"Struewing JP, Hartge P, Wacholder S et al (1997) The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 336:1401\u20131408","journal-title":"N Engl J Med"},{"key":"9311_CR6","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1093\/jnci\/94.18.1358","volume":"94","author":"D Thompson","year":"2002","unstructured":"Thompson D, Easton DF (2002) Cancer incidence in BRCA1 mutation carriers. J Natl Cancer Inst 94:1358\u20131365","journal-title":"J Natl Cancer Inst"},{"key":"9311_CR7","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1200\/JCO.2005.03.6772","volume":"24","author":"S Chen","year":"2006","unstructured":"Chen S, Iversen ES, Friebel T et al (2006) Characterization of BRCA1 and BRCA2 mutations in a large United States sample. J Clin Oncol 24:863\u2013871","journal-title":"J Clin Oncol"},{"key":"9311_CR8","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/ijc.22817","volume":"121","author":"MJ Bermejo-Perez","year":"2007","unstructured":"Bermejo-Perez MJ, Marquez-Calderon S, Llanos-Mendez A (2007) Effectiveness of preventive interventions in BRCA1\/2 gene mutation carriers: a systematic review. Int J Cancer 121:225\u2013231","journal-title":"Int J Cancer"},{"key":"9311_CR9","unstructured":"National Institute for Health and Clinical Excellence (NHS) NICE Guideline Familial Breast Cancer. 25-10-2006"},{"key":"9311_CR10","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/jama.292.11.1317","volume":"292","author":"E Warner","year":"2004","unstructured":"Warner E, Plewes DB, Hill KA et al (2004) Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 292:1317\u20131325","journal-title":"JAMA"},{"key":"9311_CR11","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1056\/NEJM199901143400201","volume":"340","author":"LC Hartmann","year":"1999","unstructured":"Hartmann LC, Schaid DJ, Woods JE et al (1999) Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med 340:77\u201384","journal-title":"N Engl J Med"},{"key":"9311_CR12","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1056\/NEJM200107193450301","volume":"345","author":"H Meijers-Heijboer","year":"2001","unstructured":"Meijers-Heijboer H, van GB, van Putten WL et al (2001) Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 345:159\u2013164","journal-title":"N Engl J Med"},{"key":"9311_CR13","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1200\/JCO.2004.04.188","volume":"22","author":"TR Rebbeck","year":"2004","unstructured":"Rebbeck TR, Friebel T, Lynch HT et al (2004) Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE study group. J Clin Oncol 22:1055\u20131062","journal-title":"J Clin Oncol"},{"key":"9311_CR14","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1006\/pmed.2000.0684","volume":"31","author":"C Lerman","year":"2000","unstructured":"Lerman C, Hughes C, Croyle RT et al (2000) Prophylactic surgery decisions and surveillance practices one year following BRCA1\/2 testing. Prev Med 31:75\u201380","journal-title":"Prev Med"},{"key":"9311_CR15","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/S0140-6736(00)02347-3","volume":"355","author":"EJ Meijers-Heijboer","year":"2000","unstructured":"Meijers-Heijboer EJ, Verhoog LC, Brekelmans CT et al (2000) Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation. Lancet 355:2015\u20132020","journal-title":"Lancet"},{"key":"9311_CR16","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s10689-005-4215-3","volume":"4","author":"KA Metcalfe","year":"2005","unstructured":"Metcalfe KA, Snyder C, Seidel J et al (2005) The use of preventive measures among healthy women who carry a BRCA1 or BRCA2 mutation. Fam Cancer 4:97\u2013103","journal-title":"Fam Cancer"},{"key":"9311_CR17","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1200\/JCO.2002.20.5.1260","volume":"20","author":"L Scheuer","year":"2002","unstructured":"Scheuer L, Kauff N, Robson M et al (2002) Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers. J Clin Oncol 20:1260\u20131268","journal-title":"J Clin Oncol"},{"key":"9311_CR18","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/ajmg.a.10102","volume":"118A","author":"JR Botkin","year":"2003","unstructured":"Botkin JR, Smith KR, Croyle RT et al (2003) Genetic testing for a BRCA1 mutation: prophylactic surgery and screening behavior in women 2\u00a0years post testing. Am J Med Genet A 118A:201\u2013209","journal-title":"Am J Med Genet A"},{"key":"9311_CR19","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/sj.bjc.6603610","volume":"96","author":"C Foster","year":"2007","unstructured":"Foster C, Watson M, Eeles R et al (2007) Predictive genetic testing for BRCA1\/2 in a UK clinical cohort: three-year follow-up. Br J Cancer 96:718\u2013724","journal-title":"Br J Cancer"},{"key":"9311_CR20","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0738-3991(01)00119-7","volume":"43","author":"EM Bleiker","year":"2001","unstructured":"Bleiker EM, Grosfeld FJ, Hahn DE et al (2001) Psychosocial care in family cancer clinics in The Netherlands: a brief report. Patient Educ Couns 43:205\u2013209","journal-title":"Patient Educ Couns"},{"key":"9311_CR21","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1200\/JCO.2000.18.11.2250","volume":"18","author":"B Meiser","year":"2000","unstructured":"Meiser B, Butow P, Friedlander M et al (2000) Intention to undergo prophylactic bilateral mastectomy in women at increased risk of developing hereditary breast cancer. J Clin Oncol 18:2250\u20132257","journal-title":"J Clin Oncol"},{"key":"9311_CR22","doi-asserted-by":"crossref","unstructured":"Lostumbo L, Carbine N, Wallace J et al. (2004) Prophylactic mastectomy for the prevention of breast cancer. Cochrane Database Syst Rev 4:CD002748. Review","DOI":"10.1002\/14651858.CD002748.pub2"},{"key":"9311_CR23","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1200\/JCO.2003.09.052","volume":"21","author":"H Meijers-Heijboer","year":"2003","unstructured":"Meijers-Heijboer H, Brekelmans CT, Menke-Pluymers M et al (2003) Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation. J Clin Oncol 21:1675\u20131681","journal-title":"J Clin Oncol"},{"key":"9311_CR24","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1038\/sj.bjc.6600988","volume":"88","author":"S Dijk van","year":"2003","unstructured":"van Dijk S, Otten W, Zoeteweij MW et al (2003) Genetic counselling and the intention to undergo prophylactic mastectomy: effects of a breast cancer risk assessment. Br J Cancer 88:1675\u20131681","journal-title":"Br J Cancer"},{"key":"9311_CR25","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1200\/JCO.2006.10.5494","volume":"26","author":"S Dijk van","year":"2008","unstructured":"van Dijk S, van Roosmalen MS, Otten W et al (2008) Decision making regarding prophylactic mastectomy: stability of preferences and the impact of anticipated feelings of regret. J Clin Oncol 26:2358\u20132363","journal-title":"J Clin Oncol"},{"key":"9311_CR26","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1200\/JCO.2003.10.100","volume":"21","author":"I Oostrom van","year":"2003","unstructured":"van Oostrom I, Meijers-Heijboer H, Lodder LN et al (2003) Long-term psychological impact of carrying a BRCA1\/2 mutation and prophylactic surgery: a 5-year follow-up study. J Clin Oncol 21:3867\u20133874","journal-title":"J Clin Oncol"},{"key":"9311_CR27","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1089\/gtmb.2008.0067","volume":"13","author":"MS Beattie","year":"2009","unstructured":"Beattie MS, Crawford B, Lin F et al (2009) Uptake, time course, and predictors of risk-reducing surgeries in BRCA carriers. Genet Test Mol Biomarkers 13:51\u201356","journal-title":"Genet Test Mol Biomarkers"},{"key":"9311_CR28","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/annonc\/mdm537","volume":"19","author":"N Hoogerbrugge","year":"2008","unstructured":"Hoogerbrugge N, Kamm YJ, Bult P et al (2008) The impact of a false-positive MRI on the choice for mastectomy in BRCA mutation carriers is limited. Ann Oncol 19:655\u2013659","journal-title":"Ann Oncol"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-009-9311-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10689-009-9311-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-009-9311-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T21:46:01Z","timestamp":1559252761000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10689-009-9311-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,5]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["9311"],"URL":"https:\/\/doi.org\/10.1007\/s10689-009-9311-3","relation":{},"ISSN":["1389-9600","1573-7292"],"issn-type":[{"value":"1389-9600","type":"print"},{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,5]]}}}